ADIPOQ and fatty liver disease: In a recent study, it was demonstrated that overexpression of adiponectin in mice on an ob/ob genetic background resulted in greater obesity, compared to non-transgenic animals, but with marked improvements in both glucose tolerance and insulin resistance, as well as reduced circulating TG and hepatic steatosis [31].